CDE Detailed Report
Disease: Stroke
Subdomain Name: Drugs
CRF: Thrombolytic
Displaying 1 - 25 of 25
Subdomain Name: Drugs
CRF: Thrombolytic
Displaying 1 - 25 of 25
| CDE ID | CDE Name | Variable Name | Definition | Short Description | Question Text | Permissible Values | Description | Data Type | Disease Specific Instructions | Disease Specific Reference | Population | Classification (e.g., Core) | Version Number | Version Date | CRF Name (CRF Module / Guidance) | Subdomain Name | Domain Name | Size | Input Restrictions | Min Value | Max Value | Measurement Type | External Id Loinc | External Id Snomed | External Id caDSR | External Id CDISC |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| C60363 | IV thrombolytic agent not started reason | IVThrombolyticAgntNotStartRsn | If NO Intravenous thrombolytic agent was initiated, documents reasons in the medical record for why no IV thrombolytic agent was started for the participant at the current hospital. | If NO Intravenous thrombolytic agent was initiated, documents reasons in the medical record for why no IV thrombolytic agent was started for the participant at the current hospital. | Reason(s) no IV thrombolytic agent started at the current hospital | Active internal bleeding (<22 days);CT findings (ICH, SAH, or major infarct signs);History of intracranial hemorrhage or brain aneurysm or vascular malformation or brain tumor;Platelets <100,000, PTT> 40 sec after heparin use, or PT > 15 or INR > 1.7, or known bleeding diathesis;Recent intracranial or spinal surgery, head trauma, or stroke (<3 mo.);Recent surgery/trauma (<15 days);SBP > 185 or DBP > 110 mmHg despite treatment;Seizure at onset;Suspicion of subarachnoid hemorrhage;Subacute Bacterial Endocarditis (SBE);Advanced age;Care-team unable to determine eligibility;Glucose < 50 or > 400 mg/dl;Increased risk of bleeding due to Acute pericarditis, SBE, Hemostatic defects, Diabetic hemorrhagic retinopathy, Septic thrombophlebitis/occluded AV cannula, or currently receiving oral anticoagulants;IV or IA thrombolytic agent given at outside hospital;Left heart thrombus;Life expectancy < 1 year or severe co-morbid illness or CMO on admission;Pregnancy;Participant/Family refused;Rapid improvement;Stroke severity nondisabling;Stroke severity - Too severe (e.g., NIHSS >22);Age > 80;Prior Stroke and Diabetes;Any anticoagulant use prior to admission (even if INR < 1.7);NIHSS > 25;CT findings of >1/3 MCA;Delay in Participant Arrival;Delay in Stroke diagnosis;In-hospital Time Delay;No IV access;MRI not feasible;CTP not feasible;Other, specify | Active internal bleeding (<22 days);CT findings (ICH, SAH, or major infarct signs);History of intracranial hemorrhage or brain aneurysm or vascular malformation or brain tumor;Platelets <100,000, PTT> 40 sec after heparin use, or PT > 15 or INR > 1.7, or known bleeding diathesis;Recent intracranial or spinal surgery, head trauma, or stroke (<3 mo.);Recent surgery/trauma (<15 days);SBP > 185 or DBP > 110 mmHg despite treatment;Seizure at onset;Suspicion of subarachnoid hemorrhage;Subacute Bacterial Endocarditis (SBE);Advanced age;Care-team unable to determine eligibility;Glucose < 50 or > 400 mg/dl;Increased risk of bleeding due to Acute pericarditis, SBE, Hemostatic defects, Diabetic hemorrhagic retinopathy, Septic thrombophlebitis/occluded AV cannula, or currently receiving oral anticoagulants;IV or IA thrombolytic agent given at outside hospital;Left heart thrombus;Life expectancy < 1 year or severe co-morbid illness or CMO on admission;Pregnancy;Participant/Family refused;Rapid improvement;Stroke severity nondisabling;Stroke severity - Too severe (e.g., NIHSS >22);Age > 80;Prior Stroke and Diabetes;Any anticoagulant use prior to admission (even if INR < 1.7);NIHSS > 25;CT findings of >1/3 MCA;Delay in Participant Arrival;Delay in Stroke diagnosis;In-hospital Time Delay;No IV access;MRI not feasible;CTP not feasible;Other, specify | Alphanumeric |
Choose all that apply. |
American Heart/American Stroke Association. (2018). Get With The Guidelines (GWTG) Stroke Patient Management Tool Coding Instructions (? 2018, American Heart/American Stroke Association). Available at: https://www.heart.org/-/media/files/professional/quality-improvement/get-with-the-guidelines/get-with-the-guidelines-stroke/stroke-fact-sheet_-final_ucm_501842.pdf?la=en; Paul Coverdell National Acute Stroke Registry | Adult;Pediatric | Supplemental | 1 | 6/10/2024 10:27 AM | Thrombolytic/Reperfusion Therapies | Drugs | Treatment/Intervention Data |
Multiple Pre-Defined Values Selected |
||||||||
| C60364 | IV thrombolytic agent not started other text | IVThrombolyticAgntNotStartOTH | The free-text field related to 'IV thrombolytic agent not started reason' specifying other text. If NO Intravenous thrombolytic agent was initiated, documents reasons in the medical record for why no IV thrombolytic agent was started for the participant at the current hospital. | The free-text field related to 'IV thrombolytic agent not started reason' specifying other text. If NO Intravenous thrombolytic agent was initiated, documents reasons in the medical record for why no IV thrombolytic agent was started for the participant a | Other, specify | Alphanumeric |
Choose all that apply. |
American Heart/American Stroke Association. (2018). Get With The Guidelines (GWTG) Stroke Patient Management Tool Coding Instructions (? 2018, American Heart/American Stroke Association). Available at: https://www.heart.org/-/media/files/professional/quality-improvement/get-with-the-guidelines/get-with-the-guidelines-stroke/stroke-fact-sheet_-final_ucm_501842.pdf?la=en; Paul Coverdell National Acute Stroke Registry | Adult;Pediatric | Supplemental | 1 | 6/10/2024 1:38 PM | Thrombolytic/Reperfusion Therapies | Drugs | Treatment/Intervention Data | 255 |
Free-Form Entry |
|||||||||
| C60365 | IV thrombolytic agent not started MRI selection treatment beyond 4.5 hour reason | IVTANtStMRITrtSctByd4HlfHrRsn | If NO Intravenous thrombolytic agent was initiated for the participant/subject treated using MRI imaging selection beyond 4.5 hours, documents reasons in the medical record for why no IV thrombolytic agent was started for the participant at the current hospital. | If NO Intravenous thrombolytic agent was initiated for the participant/subject treated using MRI imaging selection beyond 4.5 hours, documents reasons in the medical record for why no IV thrombolytic agent was started for the participant at the current ho | Other reasons thrombolytic agent is not started for patients treated using MRI imaging selection beyond 4.5 hours | Treatment cannot be started within 4.5 hours of symptom recognition;Age > 80;Parenchymal hyperintensity visible on FLAIR;NIHSS > 25;CT findings of >1/3 MCA or >50% of ACA or PCA territories, or > 100ml;Any MRI findings indicative of a high risk of SICH | Treatment cannot be started within 4.5 hours of symptom recognition;Age > 80;Parenchymal hyperintensity visible on FLAIR;NIHSS > 25;CT findings of >1/3 MCA or >50% of ACA or PCA territories, or > 100ml;Any MRI findings indicative of a high risk of SICH | Alphanumeric |
Choose all that apply. |
No references available | Adult;Pediatric | Exploratory | 1 | 6/10/2024 1:42 PM | Thrombolytic/Reperfusion Therapies | Drugs | Treatment/Intervention Data |
Multiple Pre-Defined Values Selected |
||||||||
| C60366 | IV thrombolytic agent at another hospital indicator | IVThrmblAgntAnotherHospitalInd | Indicator of whether IV thrombolytic agent was initiated for the participant at an outside hospital | Indicator of whether IV thrombolytic agent was initiated for the participant at an outside hospital | Was IV thrombolytic agent initiated at an outside hospital? | Yes;No;Unknown | Yes;No;Unknown | Alphanumeric |
Choose one. |
American Heart/American Stroke Association. (2018). Get With The Guidelines (GWTG) Stroke Patient Management Tool Coding Instructions (? 2018, American Heart/American Stroke Association). Available at: https://www.heart.org/-/media/files/professional/quality-improvement/get-with-the-guidelines/get-with-the-guidelines-stroke/stroke-fact-sheet_-final_ucm_501842.pdf?la=en; Paul Coverdell National Acute Stroke Registry | Adult;Pediatric | Supplemental | 1 | 6/10/2024 1:45 PM | Thrombolytic/Reperfusion Therapies | Drugs | Treatment/Intervention Data |
Single Pre-Defined Value Selected |
||||||||
| C14399 | IV tPA not started reason | IVtPANotStartRsn | If NO Intravenous Tissue Plasminogen Activator (IV tPA) was initiated, documents reasons in the medical record for why no IV tPA was started for the participant/subject at your hospital. Were one or more of the following reasons for not administering IV thrombolytic therapy at this hospital explicitly documented by a physician, advance practice nurse, or physician assistant's notes in the medical record? | If NO Intravenous Tissue Plasminogen Activator (IV tPA) was initiated, documents reasons in the medical record for why no IV tPA was started for the participant/subject at your hospital. Were one or more of the following reasons for not administering IV thrombolytic therapy at this hospital explicitly documented by a physician, advance practice nurse, or physician assistant's notes in the medical record | Reason(s) no IV tPA started at this hospital | Active internal bleeding (<22 days);CT findings (ICH, SAH, or major infarct signs);History of intracranial hemorrhage or brain aneurysm or vascular malformation or brain tumor;Platelets <100,000, PTT> 40 sec after heparin use, or PT > 15 or INR > 1.7, or known bleeding diathesis;Recent intracranial or spinal surgery, head trauma, or stroke (<3 mo.);Recent surgery/trauma (<15 days);SBP > 185 or DBP > 110 mmHg despite treatment;Seizure at onset;Suspicion of subarachnoid hemorrhage;Subacute Bacterial Endocarditis (SBE);Advanced age;Care-team unable to determine eligibility;Glucose < 50 or > 400 mg/dl;Increased risk of bleeding due to Acute pericarditis, SBE, Hemostatic defects, Diabetic hemorrhagic retinopathy, Septic thrombophlebitis/occluded AV cannula, or currently receiving oral anticoagulants;IV or IA tPA given at outside hospital;Left heart thrombus;Life expectancy < 1 year or severe co-morbid illness or CMO on admission;Pregnancy;Patient/Family refused;Rapid improvement;Stroke severity - Too severe (e.g., NIHSS >22);Age > 80;Prior Stroke and Diabetes;Any anticoagulant use prior to admission (even if INR < 1.7);NIHSS > 25;CT findings of >1/3 MCA;Delay in Patient Arrival;Delay in Stroke diagnosis;In-hospital Time Delay;No IV access;Other, specify;Stroke severity nondisabling;MRI not feasible;CTP not feasible | Active internal bleeding (<22 days);CT findings (ICH, SAH, or major infarct signs);History of intracranial hemorrhage or brain aneurysm or vascular malformation or brain tumor;Platelets <100,000, PTT> 40 sec after heparin use, or PT > 15 or INR > 1.7, or known bleeding diathesis;Recent intracranial or spinal surgery, head trauma, or stroke (<3 mo.);Recent surgery/trauma (<15 days);SBP > 185 or DBP > 110 mmHg despite treatment;Seizure at onset;Suspicion of subarachnoid hemorrhage;Subacute Bacterial Endocarditis (SBE);Advanced age;Care-team unable to determine eligibility;Glucose < 50 or > 400 mg/dl;Increased risk of bleeding due to Acute pericarditis, SBE, Hemostatic defects, Diabetic hemorrhagic retinopathy, Septic thrombophlebitis/occluded AV cannula, or currently receiving oral anticoagulants;IV or IA tPA given at outside hospital;Left heart thrombus;Life expectancy < 1 year or severe co-morbid illness or CMO on admission;Pregnancy;Patient/Family refused;Rapid improvement;Stroke severity - Too severe (e.g., NIHSS >22);Age > 80;Prior Stroke and Diabetes;Any anticoagulant use prior to admission (even if INR < 1.7);NIHSS > 25;CT findings of >1/3 MCA;Delay in Patient Arrival;Delay in Stroke diagnosis;In-hospital Time Delay;No IV access;Other, specify;Stroke severity nondisabling;MRI not feasible;CTP not feasible | Alphanumeric |
Choose all that apply. |
American Heart/American Stroke Association. (2018). Get With The Guidelines (GWTG) Stroke Patient Management Tool Coding Instructions (© 2018, American Heart/American Stroke Association). Available at: https://www.heart.org/-/media/files/professional/quality-improvement/get-with-the-guidelines/get-with-the-guidelines-stroke/stroke-fact-sheet_-final_ucm_501842.pdf?la=en; Paul Coverdell National Acute Stroke Registry | Adult;Pediatric | Supplemental | 3.00 | 2013-06-21 00:00:00.0 | Thrombolytic/Reperfusion Therapies | Drugs | Treatment/Intervention Data |
Multiple Pre-Defined Values Selected |
||||||||
| C14400 | IV tPA at another hospital indicator | IVtPAAnotherHospitalInd | Indicates whether IV tPA was initiated for the participant/subject at an outside hospital | Indicates whether IV tPA was initiated for the participant/subject at an outside hospital | Was IV tPA initiated at an outside hospital | Yes;No;Unknown | Yes;No;Unknown | Alphanumeric |
Choose one. |
American Heart/American Stroke Association. (2018). Get With The Guidelines (GWTG) Stroke Patient Management Tool Coding Instructions (© 2018, American Heart/American Stroke Association). Available at: https://www.heart.org/-/media/files/professional/quality-improvement/get-with-the-guidelines/get-with-the-guidelines-stroke/stroke-fact-sheet_-final_ucm_501842.pdf?la=en; Paul Coverdell National Acute Stroke Registry | Adult;Pediatric | Supplemental | 3.00 | 2013-06-21 00:00:00.0 | Thrombolytic/Reperfusion Therapies | Drugs | Treatment/Intervention Data |
Single Pre-Defined Value Selected |
||||||||
| C18927 | IV tPA not started other text | IVtPANotStartOTH | The free-text field related to 'IV tPA not started reason' specifying other text. If NO Intravenous Tissue Plasminogen Activator (IV tPA) was initiated, documents reasons in the medical record for why no IV tPA was started for the participant/subject at your hospital. Were one or more of the following reasons for not administering IV thrombolytic therapy at this hospital explicitly documented by a physician, advance practice nurse, or physician assistant's notes in the medical record? | The free-text field related to 'IV tPA not started other text' specifying other text. If NO Intravenous Tissue Plasminogen Activator initiated, documents reasons in the medical record for why no IV tPA was started | Other, specify | Alphanumeric |
Choose all that apply. |
American Heart/American Stroke Association. (2018). Get With The Guidelines (GWTG) Stroke Patient Management Tool Coding Instructions (© 2018, American Heart/American Stroke Association). Available at: https://www.heart.org/-/media/files/professional/quality-improvement/get-with-the-guidelines/get-with-the-guidelines-stroke/stroke-fact-sheet_-final_ucm_501842.pdf?la=en; Paul Coverdell National Acute Stroke Registry | Adult;Pediatric | Supplemental | 3.00 | 2013-06-21 00:00:00.0 | Thrombolytic/Reperfusion Therapies | Drugs | Treatment/Intervention Data | 4000 |
Free-Form Entry |
|||||||||
| C58852 | IV tPA not started MRI selection treatment beyond 4.5 hour reason | IVtPANtStMRITrtSctByd4HlfHrRsn | If NO Intravenous Tissue Plasminogen Activator (IV tPA) was initiated for the participant/subject treated using MRI imaging selection beyond 4.5 hours, documents reasons in the medical record for why no IV tPA was started for the participant/subject at your hospital. Were one or more of the following reasons for not administering IV thrombolytic therapy at this hospital explicitly documented by a physician, advance practice nurse, or physician assistant's notes in the medical record? | If NO Intravenous Tissue Plasminogen Activator (IV tPA) was initiated for the participant/subject treated using MRI imaging selection beyond 4.5 hours, documents reasons in the medical record for why no IV tPA was started for the participant/subject at your hospital. Were one or more of the following reasons for not administering IV thrombolytic therapy at this hospital explicitly documented by a physician, advance practice nurse, or physician assistant's notes in the medical record | Other reasons tPA is not started for patients treated using MRI imaging selection beyond 4.5 hours | Treatment cannot be started within 4.5 hours of symptom recognition;Age > 80;Parenchymal hyperintensity visible on FLAIR;NIHSS > 25;CT findings of >1/3 MCA or >50% of ACA or PCA territories, or > 100ml;Any MRI findings indicative of a high risk of SICH | Treatment cannot be started within 4.5 hours of symptom recognition;Age > 80;Parenchymal hyperintensity visible on FLAIR;NIHSS > 25;CT findings of >1/3 MCA or >50% of ACA or PCA territories, or > 100ml;Any MRI findings indicative of a high risk of SICH | Alphanumeric |
Choose all that apply. |
No references available | Adult;Pediatric | Exploratory | 1.00 | 2020-05-18 08:48:38.0 | Thrombolytic/Reperfusion Therapies | Drugs | Treatment/Intervention Data |
Multiple Pre-Defined Values Selected |
||||||||
| C60360 | IV thrombolytic agent total dose | IVThrombolyticAgntTtlDose | Dose of IV thrombolytic agent, in mg, given to the participant | Dose of IV thrombolytic agent, in mg, given to the participant | Total IV thrombolytic agent dose given | Numeric Values |
Record the numeric dose of thrombolytic agent in mg. It is important to consult these other data elements when calculating the IV thrombolytic agent dose: Stroke Onset Time/ Time Participant Last Seen Well and Body Weight in kilograms. |
No references available | Adult;Pediatric | Supplemental | 1 | 6/10/2024 10:08 AM | Thrombolytic/Reperfusion Therapies | Drugs | Treatment/Intervention Data |
Free-Form Entry |
0 | 300 | milligram | |||||||
| C60361 | IV thrombolytic agent type | IVThrombolyticAgntTyp | Type of IV thrombolytic agent given to the participant | Type of IV thrombolytic agent given to the participant | Type of IV thrombolytic agent used | Alteplase;Tenecteplase;Other, specify | Alteplase;Tenecteplase;Other, specify | Alphanumeric |
Choose all that apply. |
No references available | Adult;Pediatric | Supplemental | 1 | 6/10/2024 10:12 AM | Thrombolytic/Reperfusion Therapies | Drugs | Treatment/Intervention Data |
Multiple Pre-Defined Values Selected |
||||||||
| C60362 | IV thrombolytic agent type other text | IVThrombolyticAgntTypOTH | The free-text field related to 'IV thrombolytic agent type' specifying other text. | The free-text field related to 'IV thrombolytic agent type' specifying other text. | Other, specify | Alphanumeric |
The free-text field related to 'IV thrombolytic agent type' specifying other text. |
No references available | Adult;Pediatric | Supplemental | 1 | 6/10/2024 10:24 AM | Thrombolytic/Reperfusion Therapies | Drugs | Treatment/Intervention Data | 255 |
Free-Form Entry |
|||||||||
| C58857 | Angiographic image last date and time | AngiographicImageLstDateTime | Date (and time, if applicable and known) of last angiographic image for the participant/subject | Date (and time, if applicable and known) of last angiographic image for the participant/subject | Date and Time of last angiographic image or the end time for mechanical/pharmacologic intervention | Date or Date & Time |
If time of the last mechanical or pharmacological intervention not available, use the time on the last angiographic image. Record the date/time according to the ISO 8601, the International Standard for the representation of dates and times (http://www.iso.org/iso/home.html). The date/time should be recorded to the level of granularity known (e.g., year, year and month, complete date plus hours and minutes, etc.). |
No references available | Adult;Pediatric | Supplemental | 1.00 | 2020-05-18 09:09:50.0 | Thrombolytic/Reperfusion Therapies | Drugs | Treatment/Intervention Data |
Free-Form Entry |
||||||||||
| C14410 | Intra-sinus intervention initiated date and time | IntrasinIntrvntInitiatDateTime | Date (and time, if applicable and known) intra-sinus (IS) intervention (i.e., for cerebral venous thrombosis) was initiated at this hospital or ED | Date (and time, if applicable and known) intra-sinus (IS) intervention (i.e., for cerebral venous thrombosis) was initiated at this hospital or ED | Date and Time intra-sinus intervention initiated | Date or Date & Time |
The start time for IS therapy should be either the date and time on the angio showing evidence of treatment, or the start time of the infusion or mechanical deployment if the angio time is not available. Record the date/time according to the ISO 8601, the International Standard for the representation of dates and times (http://www.iso.org/iso/home.html). The date/time should be recorded to the level of granularity known (e.g., year, year and month, complete date plus hours and minutes, etc.). |
No references available | Adult;Pediatric | Supplemental | 3.00 | 2013-06-21 00:00:00.0 | Thrombolytic/Reperfusion Therapies | Drugs | Treatment/Intervention Data |
Free-Form Entry |
||||||||||
| C06005 | Data collected date and time | DataCollDateTime | Date (and time, if applicable and known) the data were collected. This may be the date/time a particular examination or procedure was performed | Date (and time, if applicable and known) the data were collected. This may be the date/time a particular examination or procedure was performe | Date information collected | Date or Date & Time |
Record the date/time according to the ISO 8601, the International Standard for the representation of dates and times (http://www.iso.org/iso/home.html). The date/time should be recorded to the level of granularity known (e.g., year, year and month, complete date plus hours and minutes, etc.). |
No references available | Adult;Pediatric | Supplemental | 3.00 | 2013-07-24 21:00:23.88 | Thrombolytic/Reperfusion Therapies | Drugs | Treatment/Intervention Data |
Free-Form Entry |
||||||||||
| C14411 | Investigational or experimental protocol for thrombolysis indicator | InvestExpProtThrombolysInd | Whether medical records suggest some kind of investigational thrombolytic protocol was used during provision of care | Whether medical records suggest some kind of investigational thrombolytic protocol was used during provision of care | Do the medical records suggest any type of investigational or experimental protocol for thrombolysis was used during provision of care | Yes;No;Unknown | Yes;No;Unknown | Alphanumeric |
Choose one. If yes, explain the protocol used. |
American Heart/American Stroke Association. (2018). Get With The Guidelines (GWTG) Stroke Patient Management Tool Coding Instructions (© 2018, American Heart/American Stroke Association). Available at: https://www.heart.org/-/media/files/professional/quality-improvement/get-with-the-guidelines/get-with-the-guidelines-stroke/stroke-fact-sheet_-final_ucm_501842.pdf?la=en; Paul Coverdell National Acute Stroke Registry | Adult;Pediatric | Supplemental | 3.00 | 2013-06-21 00:00:00.0 | Thrombolytic/Reperfusion Therapies | Drugs | Treatment/Intervention Data |
Single Pre-Defined Value Selected |
||||||||
| C14401 | Intra-arterial (IA) procedure initiated indicator | IAProcInitInd | Indicates whether an Intra-arterial (IA) procedure was initiated for participant/ subject at this hospital | Indicates whether an Intra-arterial (IA) procedure was initiated for participant/ subject at this hospita | Was an IA procedure initiated at this hospital | Yes;No;Unknown | Yes;No;Unknown | Alphanumeric |
Choose one. Endovascular procedures include mechanical thrombectomy and all uses of intra-arterial thrombolytic therapy. Mechanical thrombectomy may be used alone or in conjunction with intra-arterial thrombolytic therapy. |
American Heart/American Stroke Association. (2018). Get With The Guidelines (GWTG) Stroke Patient Management Tool Coding Instructions (© 2018, American Heart/American Stroke Association). Available at: https://www.heart.org/-/media/files/professional/quality-improvement/get-with-the-guidelines/get-with-the-guidelines-stroke/stroke-fact-sheet_-final_ucm_501842.pdf?la=en; Paul Coverdell National Acute Stroke Registry | Adult;Pediatric | Supplemental-Highly Recommended | 3.00 | 2013-06-21 00:00:00.0 | Thrombolytic/Reperfusion Therapies | Drugs | Treatment/Intervention Data |
Single Pre-Defined Value Selected |
||||||||
| C58579 | Investigational or experimental protocol for thrombolysis text | InvestExpProtThrombolysTxt | Free-text field to specify what type of investigational thrombolytic protocol was used during provision of care | Free-text field to specify what type of investigational thrombolytic protocol was used during provision of care | If YES, explain the protocol used | Alphanumeric | American Heart/American Stroke Association. (2018). Get With The Guidelines (GWTG) Stroke Patient Management Tool Coding Instructions (© 2018, American Heart/American Stroke Association). Available at: https://www.heart.org/-/media/files/professional/quality-improvement/get-with-the-guidelines/get-with-the-guidelines-stroke/stroke-fact-sheet_-final_ucm_501842.pdf?la=en; Paul Coverdell National Acute Stroke Registry | Adult;Pediatric | Supplemental | 3.00 | 2013-06-21 00:00:00.0 | Thrombolytic/Reperfusion Therapies | Drugs | Treatment/Intervention Data | 255 |
Free-Form Entry |
||||||||||
| C14402 | Intra-arterial (IA) procedure type | IAProcTyp | If intra-arterial (IA) procedure was initiated, describes the type of intra-arterial (IA) procedure performed on participant/ subject at this hospital | If intra-arterial (IA) procedure was initiated, describes the type of intra-arterial (IA) procedure performed on participant/ subject at this hospital | Type of IA procedure | Pharmacological;Mechanical;Both | Pharmacological;Mechanical;Both | Alphanumeric |
Choose one. |
No references available | Adult;Pediatric | Supplemental-Highly Recommended | 3.00 | 2013-06-21 00:00:00.0 | Thrombolytic/Reperfusion Therapies | Drugs | Treatment/Intervention Data |
Single Pre-Defined Value Selected |
||||||||
| C14403 | Intra-arterial (IA) procedure groin puncture date and time | IAProcGroinPuncDateTime | Date (and time, if applicable and known) of groin puncture on the participant/ subject for the intra-arterial (IA) procedure | Date (and time, if applicable and known) of groin puncture on the participant/ subject for the intra-arterial (IA) procedure | Date and Time of groin puncture for IA procedure | Date or Date & Time |
Record the date/time according to the ISO 8601, the International Standard for the representation of dates and times (http://www.iso.org/iso/home.html). The date/time should be recorded to the level of granularity known (e.g., year, year and month, complete date plus hours and minutes, etc.). |
No references available | Adult;Pediatric | Supplemental | 3.00 | 2013-06-21 00:00:00.0 | Thrombolytic/Reperfusion Therapies | Drugs | Treatment/Intervention Data |
Free-Form Entry |
||||||||||
| C14404 | Intra-arterial (IA) catheter-based reperfusion initiated date and time | IACathBasdReperfsInitDateTime | Date (and time, if applicable and known) of last intra-arterial (IA) catheter-based reperfusion initiated for the participant/ subject at this hospital or ED | Date (and time, if applicable and known) of last intra-arterial (IA) catheter-based reperfusion initiated for the participant/ subject at this hospital or ED | Date and Time IA catheter-based reperfusion initiated | Date or Date & Time |
The start time for endovascular reperfusion therapy should be either the date and time on the angio showing evidence of treatment, or the start time of the infusion or mechanical deployment if the angio time is not available. Record the date/time according to the ISO 8601, the International Standard for the representation of dates and times (http://www.iso.org/iso/home.html). The date/time should be recorded to the level of granularity known (e.g., year, year and month, complete date plus hours and minutes, etc.). |
American Heart/American Stroke Association. (2018). Get With The Guidelines (GWTG) Stroke Patient Management Tool Coding Instructions (© 2018, American Heart/American Stroke Association). Available at: https://www.heart.org/-/media/files/professional/quality-improvement/get-with-the-guidelines/get-with-the-guidelines-stroke/stroke-fact-sheet_-final_ucm_501842.pdf?la=en; Paul Coverdell National Acute Stroke Registry | Adult;Pediatric | Supplemental | 3.00 | 2013-06-21 00:00:00.0 | Thrombolytic/Reperfusion Therapies | Drugs | Treatment/Intervention Data |
Free-Form Entry |
||||||||||
| C14405 | Intervention mechanical or pharmacological end time | IntrvntMechnPharmacEndTime | The end time for mechanical, pharmacologic intervention for the participant/subject | The end time for mechanical, pharmacologic intervention for the participant/subject | Date and Time of last angiographic image or the end time for mechanical/pharmacologic intervention | Date or Date & Time |
If time of the last mechanical or pharmacological intervention not available, use the time on the last angiographic image. Record the date/time according to the ISO 8601, the International Standard for the representation of dates and times (http://www.iso.org/iso/home.html). The date/time should be recorded to the level of granularity known (e.g., year, year and month, complete date plus hours and minutes, etc.). |
No references available | Adult;Pediatric | Supplemental | 3.00 | 2013-06-21 00:00:00.0 | Thrombolytic/Reperfusion Therapies | Drugs | Treatment/Intervention Data |
Free-Form Entry |
||||||||||
| C14406 | Intra-arterial (IA) catheter-based reperfusion other hospital indicator | IACathBasdReperfsnOthHospInd | Indicates whether intra-arterial (IA) catheter-based reperfusion was initiated for the participant/subject at an outside hospital | Indicates whether intra-arterial (IA) catheter-based reperfusion was initiated for the participant/subject at an outside hospital | Was IA catheter-based reperfusion initiated at an outside hospital | Yes;No;Unknown | Yes;No;Unknown | Alphanumeric |
Choose one. |
American Heart/American Stroke Association. (2018). Get With The Guidelines (GWTG) Stroke Patient Management Tool Coding Instructions (© 2018, American Heart/American Stroke Association). Available at: https://www.heart.org/-/media/files/professional/quality-improvement/get-with-the-guidelines/get-with-the-guidelines-stroke/stroke-fact-sheet_-final_ucm_501842.pdf?la=en; Paul Coverdell National Acute Stroke Registry | Adult;Pediatric | Supplemental | 3.00 | 2013-06-21 00:00:00.0 | Thrombolytic/Reperfusion Therapies | Drugs | Treatment/Intervention Data |
Single Pre-Defined Value Selected |
||||||||
| C14407 | Intra-sinus intervention indicator | IntrasinIntrvntInd | Indicates whether the participant/subject received any intra-sinus (i.e., for cerebral venous thrombosis) intervention | Indicates whether the participant/subject received any intra-sinus (i.e., for cerebral venous thrombosis) intervention | Was an intra-sinus intervention performed | Yes;No;Unknown | Yes;No;Unknown | Alphanumeric |
Choose one. |
No references available | Adult;Pediatric | Supplemental | 3.00 | 2013-06-21 00:00:00.0 | Thrombolytic/Reperfusion Therapies | Drugs | Treatment/Intervention Data |
Single Pre-Defined Value Selected |
||||||||
| C14408 | Intra-sinus procedure type | IntrasinProcedTyp | If intra-sinus (i.e., for cerebral venous thrombosis) intervention was received, specifies the type of intra-sinus procedure performed on the participant/subject at this hospital | If intra-sinus (i.e., for cerebral venous thrombosis) intervention was received, specifies the type of intra-sinus procedure performed on the participant/subject at this hospital | Type of intra-sinus procedure | Pharmacological;Mechanical;Both | Pharmacological;Mechanical;Both | Alphanumeric |
Choose one. |
No references available | Adult;Pediatric | Supplemental | 3.00 | 2013-06-21 00:00:00.0 | Thrombolytic/Reperfusion Therapies | Drugs | Treatment/Intervention Data |
Single Pre-Defined Value Selected |
||||||||
| C14409 | Intra-sinus intervention groin puncture date and time | IntrasinIntrvntGrnPuncDateTime | Date (and time, if applicable and known) of groin puncture on the participant/ subject for intra-sinus intervention | Date (and time, if applicable and known) of groin puncture on the participant/ subject for intra-sinus intervention | Date and Time of groin puncture for intra-sinus procedure | Date or Date & Time |
Record the date/time according to the ISO 8601, the International Standard for the representation of dates and times (http://www.iso.org/iso/home.html). The date/time should be recorded to the level of granularity known (e.g., year, year and month, complete date plus hours and minutes, etc.). |
No references available | Adult;Pediatric | Supplemental | 3.00 | 2013-06-21 00:00:00.0 | Thrombolytic/Reperfusion Therapies | Drugs | Treatment/Intervention Data |
Free-Form Entry |
